Meet the DAHS Associate Dean and Chair
Location: Bondurant Hall, UNC School of Medicine
Education and Training:
- BS, Child Psychology, Juniata College
- MA, Clinical Psychology, Minor: School Psychology, Western Kentucky University
- PhD, School Psychology, Minors: Developmental Neuropsychology, Behavioral Pediatrics and Counseling and Administration, University of Georgia
Dr. Hooper’s interests revolve around training and expertise in child neuropsychology, with specific activities devoted to outreach, research, and clinical endeavors. Dr. Hooper directs a long-standing Child and Adolescent Neuropsychology Service through the Carolina Institute for Developmental Disabilities where he sees children and their families with a wide variety of neurodevelopment and acquired neurological disorders. In the training arena, this clinic has allowed for the participation of trainees across a number of different disciplines. In addition to the clinical training experiences provided via the Child and Adolescent Neuropsychology Service, Dr. Hooper conducts an annual class via the UNC School of Education that addresses core issues in brain development, brain structure, and brain functions, and how these factors contribute to the neurological basis of childhood exceptionalities. His research has focused on increasing the understanding of the neurobiological bases of childhood disorders, with a particular emphasis on phenotypic neurocognitive functioning. To date, he has engaged in efforts to examine the neurocognitive abilities of children with Turner Syndrome, Traumatic Brain Injury, Early Onset Childhood Schizophrenia, Post Traumatic Stress Disorder, 22q11.2 Deletion Syndrome, Childhood Maltreatment, Adolescent Substance Abuse (Alcohol, Cannabis), Learning Disabilities (Dyslexia, Writing Disorders), Chronic Kidney Disease, Fragile X Syndrome, and Autism Spectrum Disorders. Dr. Hooper’s research efforts also have led to working on dedicated interventions for improving the phenotypic weaknesses presented in many childhood disorders and using neurocognitive measurement to determine treatment effectiveness across pharmacological, social-behavioral, and educational interventions. Future research endeavors will permit examination of the genetic to brain to behavior to treatment linkages.